[New approach for the studies on Alzheimer's disease: a beta 1-42 and acetylcholine].
Hoshi
M
M
Mitsubishi Kasei Institute of Life Sciences, Tokyo.
D000109:Acetylcholine / Q000378:metabolism*; D000544:Alzheimer Disease / Q000209:etiology / Q000378:metabolism; D016229:Amyloid beta-Peptides / Q000378:metabolism / Q000502:physiology*; D053327:Apolipoprotein E4; D001057:Apolipoproteins E / Q000502:physiology; D016923:Cell Death; D002799:Cholinergic Fibers; D006801:Humans; D008928:Mitochondria / Q000201:enzymology; D010446:Peptide Fragments / Q000378:metabolism / Q000502:physiology*; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism
D016229:Amyloid beta-Peptides; D053327:Apolipoprotein E4; D001057:Apolipoproteins E; D010446:Peptide Fragments; D011768:Pyruvate Dehydrogenase Complex; C075222:amyloid beta-protein (1-42); D000109:Acetylcholine